Sign in

NCT06630559Active, not recruitingPhase 3

A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P55 With Cosentyx in Patients With Moderate to Severe Plaque Psoriasis

Source: ClinicalTrials.gov · Last updated 23 Feb 2026

Brief summary (registry, in English)

The goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P55 with Cosentyx in patients with moderate to severe plaque psoriasis

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
153 (actual)
First submitted
7 Oct 2024
Start date
26 May 2025
Primary completion date
18 Feb 2026
Lead sponsor
Celltrion
Diseases
Psoriasis
NCT number
NCT06630559
EU CT number
2024-513348-27-00
EudraCT number
2024-513348-27

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 153
  • From 26 May 2025 to the primary completion date, 18 Feb 2026
  • 12 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient diagnosed with forms of psoriasis other than chronic plaque-type or medication-induced psoriasis.
  • Patient who has previously received Secukinumab or any other biologic drug directly targeting Interleukin-17 or the IL-17 receptor.

Other illness

  • Patient who has allergies to any of the excipients of study drug or materials of device or any other murine and human proteins, or patient with a hypersensitivity to immunoglobulin products.

Who the study is looking for

  • \- Patient has had a diagnosis of chronic plaque psoriasis for at least 24 weeks.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Clinicmed Daniluk Nowak Sp. k.
Coordinator of this site? Confirm its status
BialystokPolandCompleted
Zdrowie Osteo-Medic S.C. Lidia i Artur Racewicz, Agnieszka i Jerzy Supronik
Coordinator of this site? Confirm its status
BiałystokPolandCompleted
Centrum Badan Klinicznych PI-House sp. z o.o.
Coordinator of this site? Confirm its status
GdanskPolandCompleted
Specjalistyczny Gabinet Dermatologiczny Aplikacyjno Badawczy Marek Brzewski Paweł Brzewski s.c.
Coordinator of this site? Confirm its status
KrakowPolandCompleted
Dermoklinika Centrum Medyczne s.c. M. Kierstan, J. Narbutt, A. Lesiak
Coordinator of this site? Confirm its status
ŁódźPolandCompleted
NZOZ Lecznica MAK MED S C
Coordinator of this site? Confirm its status
NadarzynPolandCompleted
Uniwersytecki Szpital Kliniczny Im. Fryderyka Chopina W Rzeszowie
Coordinator of this site? Confirm its status
RzeszówPolandCompleted
Clinical Best Solutions Sp. z o.o. S.K.
Coordinator of this site? Confirm its status
WarsawPolandCompleted
Klinika Reuma Park Sp. z o.o. S.K.
Coordinator of this site? Confirm its status
WarsawPolandCompleted
ROYALDERM AGNIESZKA NAWROCKA
Coordinator of this site? Confirm its status
WarszawaPolandCompleted
WroMedica I Bielicka A Strzalkowska s c
Coordinator of this site? Confirm its status
WroclawPolandCompleted
dermMedica Sp. z o.o
Coordinator of this site? Confirm its status
WroclawPolandCompleted

This page is information, not medical advice. Discuss any trial with your doctor.